News Center

Home page

Peak Report

News reports

Advanced Representatives Talk about Experience

Release time:

2023-02-22

: At the commendation meeting of Jianfeng Pharmaceutical held on March 19 , , Cao Jiankai, the advanced representative of the group and the production department of the pharmaceutical company, Wu Weisheng, the representative of the advanced collective and the general manager of the pharmaceutical company, Zhang Sihan, the representative of the outstanding scientific and technological workers, the product development department, Fan Yongmei, the representative of the outstanding marketing staff and the sales department, took the stage to share their work experience and experience. This issue of "Peak News" specially excerpts some of the main contents of the speech for colleagues to share and learn.

Seize Opportunity

Tap Potential and Increase Efficiency Work Together to Promote Development

■ Advanced Collective Representative Jinhua Pharmaceutical Company

2022

was a very unusual year. Faced with the severe epidemic prevention and control situation, pharmaceutical companies overcame the impact of epidemic control drug sales restrictions and traffic control and exceeded the responsibility system target.

Looking back on one year's work, there are mainly the following four highlights:

Seize the policy opportunity, and the Chinese Medicine Department has achieved substantial growth in sales and profits.

2022

At the beginning of the year, Jinhua City implemented a new medical insurance payment policy for Chinese herbal pieces. Hospitals did not pay more attention to brand and quality in the purchase of Chinese herbal pieces. The Department of Traditional Chinese Medicine took the initiative to attack and follow up in time, actively adopted the hospital's demands for Chinese herbal pieces under the new regulations, and carried out targeted procurement and distribution of Chinese herbal pieces in accordance with the requirements of the hospital. While fully meeting the needs of the hospital, it achieved a substantial increase in sales in key hospitals. The pharmaceutical company became one of the two suppliers of Jinhua Hospital of Traditional Chinese Medicine. Becoming the main distributor of Yongkang Hospital of Traditional Chinese Medicine, the sales revenue of the Chinese Medicine Department increased 65.43 year on year . The pharmaceutical company also formed an alliance with Jinhua traditional Chinese Medicine Hospital to participate in the activity of "thousands of regiments, thousands of villages, jointly building common prosperity, and helping villages" organized by the Agricultural Office of Jinhua Municipal CPC Committee to help Shanfeng Village, Majian Town, Lanxi City; signed an agreement with the Education Foundation of Zhejiang University of traditional Chinese Medicine to continuously strengthen the cooperative relationship with Jinhua traditional Chinese Medicine Hospital, which is an affiliated hospital of Zhejiang University of traditional Chinese Medicine. The steady growth of

hemp essence drugs has consolidated the leading position of hemp essence drugs in Jinhua region. At the beginning of

, the pharmaceutical company strengthened the cooperation between Jinhua Charity Federation and Jinhua Central Hospital to realize exclusive distribution of special drugs of Jinyi Group. The sales of hemp essence drugs increased by more than 20% and throughout the year.

Western medicine department to find ways to tap the potential to increase efficiency, sales for the first time in recent years to achieve positive growth.

Hospital plate, the salesman strengthened the communication between medical institutions and suppliers, improved the quality of service, and stabilized the basic plate. At the same time, by expanding the sales of new hemp essence drugs and other varieties to make up for the loss of centralized varieties, after efforts, sales increased by more than 44,295 million yuan year on year. 12 After the optimization of the epidemic prevention and control policy in July, the explosive growth of the four major categories of drugs, the annual sales of the third terminal sector increased year-on-year 1650 million yuan. The grass-roots hospital sector has achieved good growth in Lanxi and Wucheng districts by understanding market trends, strengthening customer visits, improving service quality, and overcoming unfavorable factors such as the reduction of distribution varieties and the impact of epidemics. In January, it regained the distribution right of Yiwu market and gradually resumed its business in some markets. The annual sales volume increased by more than 460 million yuan year on year.

The whole company is united, united, and united, which is a sufficient guarantee to overcome the epidemic and exceed the goal of accountability.

Jinhua

"4.15 " During the epidemic, in addition to strictly controlling the entry and exit of employees and outsiders, our company also required some employees living in controlled risk areas to stay in the company to avoid key positions being controlled and affecting the company's daily operations. This has also been understood and supported by relevant personnel, thus staying at the company at ease. In the end, our company has been operating normally during the outbreak. After the outbreak of the "4.15 " Jinhua epidemic, the company, as the Jinhua municipal government's epidemic prevention and control material reserve unit, cadres took the lead, organized personnel, supported the warehouse, received, distributed and transported all kinds of epidemic prevention and control materials, in the inventory of warehouse assets to generate income rent, but also contributed to the prevention and control of the epidemic in Jinhua City. The large volume of sales of Chinese medicine tablets and the explosive growth in sales of related drugs after the optimization of epidemic control measures have increased the workload of the warehouse. When the warehouse is understaffed, cadres take the lead. Salesmen, general manager office personnel, buyers and other personnel who can be vacated are all porters and shippers. They work overtime together with the warehouse keeper to ensure that the goods arriving on the same day are put into storage on the same day, the sales orders on the same day are out of storage on the same day, and it is common to work overtime until after in the evening at the beginning of each week or when the business volume.

Honor belongs to the past, we start again. In the new year, we have the opportunity to liberalize the control of the epidemic and fully resume normal operations, as well as the risk of a sharp rise in the purchase price of Chinese medicine tablets, fierce competition in the market for refined hemp drugs, and the loss of price cuts for key varieties of drug collection.

"Although the road is far, the journey will come. Although things are difficult, they will be done", accumulating steps and even thousands of miles. I believe that as long as we keep our feet on the ground, work hard, under the correct leadership and full support of the group company and the pharmaceutical company, and with the joint efforts of all employees, the 70-year-old pharmaceutical company will still be rejuvenated.

Find the right position

Keep your feet on the ground Improve yourself through learning

■ It has been seven years since Cao Jiankai

, the group's advanced representative, joined the peak family. Here I would like to share with you some experiences and thoughts in these years of work.

My first job in the company was a workshop equipment manager. At that time, I was unfamiliar with the equipment and its principles in the workshop. During the inspection and maintenance, although some of them had been learned in textbooks, I found that I could not start in actual operation. Fortunately, with the help of the teachers, I could gradually get started. Reading thousands of books is not as good as traveling thousands of miles, and reading books ten times is not as good as doing it once, which is my real feeling in the early days of my employment.

Company is preparing to build a new project in Anhui. At the time of employing people, the leader came to me. I think this is a good opportunity to learn. I thought my parents would disagree, but after a moment of silence, their words reassured me,

"Go if you have a chance! Since the company has chosen to believe you, you can do it well". So ignorant I embarked on a new journey to work in Anhui.

just arrived in Xinbeika, the strange atmosphere, strange environment, and work that I have never been in contact with, it is inevitable that I am not used to it at first, and even a little resistant, but I still stick to it. To adapt to the new job as soon as possible, we must improve our ability. During the preparation of the project, the drawings and materials of the design institute were my daily food, and the working platform gradually given by the leaders. With my previous work experience, I gradually adapted to the new job. Starting from the study of small technological transformation projects one by one, and finally being responsible for completing the installation of a workshop project independently. The experience along the way reminds me of our building's motto

-"work is practice". I have a deep understanding of this. As young people, sometimes when facing different working environments and problems, we must learn to practice ourselves, actively adapt to the environment, find our own position, keep our feet on the ground, and improve ourselves through learning. The new generation of us should also have a heart of gratitude. The company has trained us, and we should contribute to the development of the company. We cannot identify ourselves as "workers", because I think the definition of "workers" refers to a group of people who work mechanically and have no thoughts. We should learn to think, think about how to make our work fast and efficient, and how to make our work bring benefits to the company.

I will continue to work hard to improve my working ability and live up to everyone's expectations of me. Keep in mind the mission of the company, with a more enthusiastic attitude and full spirit, to contribute to our

"Centennial Peak.

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页